Antineutrophil Cytoplasmic Antibody-associated Vasculitis Clinical Trials

5 clinical trials for Antineutrophil Cytoplasmic Antibody-associated Vasculitis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — RECRUITING · PHASE4
• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) — RECRUITING · PHASE1
• CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis — RECRUITING · PHASE1
• A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in participants With Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis — COMPLETED · PHASE4
• The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects — COMPLETED · PHASE1

Refine this search